[144] Coupang, Inc. SEC Filing
Coupang insider Gaurav Anand submitted a Form 144 to notify a proposed sale of 75,350 common shares, with an aggregate market value of $2,096,990.50, to be executed on or about 08/11/2025 through Morgan Stanley Smith Barney LLC on the NYSE. The filing shows those shares were acquired by previously exercised stock options on 10/21/2020 (12,100 shares) and 12/13/2021 (63,250 shares), with payment in cash. The notice also reports recent May 2025 sales by the same person: 175,000 shares for $4,919,635.00 and 75,350 shares under a 10b5-1 plan for $1,966,921.33. The proposed sale represents approximately 0.0045% of the 1,665,262,233 shares outstanding reported in the filing, and the filer affirms no undisclosed material adverse information.
Il dirigente di Coupang Gaurav Anand ha presentato un Mod. 144 per notificare la prevista vendita di 75,350 azioni ordinarie, per un valore di mercato complessivo di $2,096,990.50, da eseguirsi in o intorno al 08/11/2025 tramite Morgan Stanley Smith Barney LLC alla NYSE. La segnalazione indica che tali azioni erano state acquisite esercitando opzioni su azioni in precedenza, il 10/21/2020 (12,100 azioni) e il 12/13/2021 (63,250 azioni), con pagamento in contanti. L'avviso riferisce inoltre vendite recenti, a maggio 2025, da parte della stessa persona: 175,000 azioni per $4,919,635.00 e 75,350 azioni nell'ambito di un piano 10b5-1 per $1,966,921.33. La vendita proposta rappresenta circa il 0.0045% delle 1,665,262,233 azioni in circolazione riportate nella documentazione, e il dichiarante attesta l'assenza di informazioni materiali sfavorevoli non divulgate.
El insider de Coupang Gaurav Anand presentó el Form 144 para notificar la propuesta de venta de 75,350 acciones ordinarias, con un valor de mercado agregado de $2,096,990.50, que se ejecutaría en o alrededor del 08/11/2025 a través de Morgan Stanley Smith Barney LLC en la NYSE. La presentación indica que esas acciones fueron adquiridas mediante opciones sobre acciones ejercidas previamente el 10/21/2020 (12,100 acciones) y el 12/13/2021 (63,250 acciones), con pago en efectivo. El aviso también informa ventas recientes en mayo de 2025 por la misma persona: 175,000 acciones por $4,919,635.00 y 75,350 acciones bajo un plan 10b5-1 por $1,966,921.33. La venta propuesta representa aproximadamente el 0.0045% de las 1,665,262,233 acciones en circulación informadas en la presentación, y el declarante afirma no poseer información adversa material no divulgada.
쿠팡 내부자 Gaurav Anand는 예정된 75,350 보통주 매각을 통지하기 위해 Form 144를 제출했으며, 총 시장 가치는 $2,096,990.50이고 08/11/2025경 NYSE에서 Morgan Stanley Smith Barney LLC를 통해 실행될 예정입니다. 제출서류에 따르면 이 주식들은 이전에 행사된 주식옵션으로 취득되었으며, 10/21/2020에 12,100주와 12/13/2021에 63,250주를 현금으로 지급하여 취득한 것으로 나타납니다. 통지서는 또한 동일 인물의 최근 2025년 5월 매각도 보고했는데, 175,000주를 $4,919,635.00에 매도했고, 10b5-1 계획에 따른 75,350주를 $1,966,921.33에 매도했습니다. 제안된 매각은 제출서류에 보고된 유통 주식 1,665,262,233주의 약 0.0045%에 해당하며, 제출자는 공개되지 않은 중대한 불리한 정보가 없음을 확인했습니다.
L'initié de Coupang, Gaurav Anand, a déposé un Form 144 pour notifier la vente proposée de 75,350 actions ordinaires, pour une valeur de marché totale de $2,096,990.50, devant être exécutée aux alentours du 08/11/2025 via Morgan Stanley Smith Barney LLC sur le NYSE. Le dossier indique que ces actions avaient été acquises par l'exercice antérieur d'options sur actions le 10/21/2020 (12,100 actions) et le 12/13/2021 (63,250 actions), avec paiement en espèces. L'avis signale également des ventes récentes en mai 2025 par la même personne : 175,000 actions pour $4,919,635.00 et 75,350 actions dans le cadre d'un plan 10b5-1 pour $1,966,921.33. La vente proposée représente environ 0.0045% des 1,665,262,233 actions en circulation déclarées dans le dossier, et le déclarant affirme ne détenir aucune information défavorable matérielle non divulguée.
Der Coupang-Insider Gaurav Anand reichte ein Form 144 ein, um einen geplanten Verkauf von 75,350 Stammaktien anzumelden, mit einem Gesamtmarktwert von $2,096,990.50, der am oder um den 08/11/2025 über Morgan Stanley Smith Barney LLC an der NYSE ausgeführt werden soll. Aus der Einreichung geht hervor, dass diese Aktien durch zuvor ausgeübte Aktienoptionen erworben wurden am 10/21/2020 (12,100 Aktien) und am 12/13/2021 (63,250 Aktien), mit Barzahlung. Die Mitteilung meldet außerdem jüngste Verkäufe im Mai 2025 derselben Person: 175,000 Aktien für $4,919,635.00 und 75,350 Aktien im Rahmen eines 10b5-1-Plans für $1,966,921.33. Der vorgeschlagene Verkauf entspricht etwa 0.0045% der in der Einreichung genannten 1,665,262,233 im Umlauf befindlichen Aktien, und der Meldende bestätigt, dass keine nicht offengelegten wesentlichen nachteiligen Informationen vorliegen.
- 10b5-1 sale is documented, indicating use of a pre-established trading plan for at least one transaction
- Acquisition details are explicit (dates and that payment was cash for exercised options), improving transparency
- Insider disposed of shares in May 2025 (175,000 and 75,350 shares), generating stated gross proceeds
- Proposed additional sale of 75,350 shares announced for 08/11/2025
Insights
TL;DR: Insider sales are disclosed but represent a very small portion of outstanding shares; limited likely market impact.
The filing notifies a proposed sale of 75,350 shares valued at $2,096,990.50 and records May 2025 disposals of 175,000 and 75,350 shares generating stated proceeds. Given the 1,665,262,233 shares outstanding in the filing, the proposed sale equals roughly 0.0045% of outstanding stock, so the direct supply shock to the market is minimal. The disclosure is clear on acquisition dates and cash payment for exercised options, allowing precise tracking of insider liquidity events.
TL;DR: Form 144 plus a noted 10b5-1 sale point to routine, pre-scheduled insider selling and formal compliance with disclosure rules.
The filing identifies a broker (Morgan Stanley Smith Barney LLC), an approximate sale date (08/11/2025), and explicitly references a 10b5-1 sale executed in May 2025. Those details indicate the filer followed recognized procedures for reporting and executing insider sales. The signature representation that no undisclosed material adverse information exists is standard and included in the notice.
Il dirigente di Coupang Gaurav Anand ha presentato un Mod. 144 per notificare la prevista vendita di 75,350 azioni ordinarie, per un valore di mercato complessivo di $2,096,990.50, da eseguirsi in o intorno al 08/11/2025 tramite Morgan Stanley Smith Barney LLC alla NYSE. La segnalazione indica che tali azioni erano state acquisite esercitando opzioni su azioni in precedenza, il 10/21/2020 (12,100 azioni) e il 12/13/2021 (63,250 azioni), con pagamento in contanti. L'avviso riferisce inoltre vendite recenti, a maggio 2025, da parte della stessa persona: 175,000 azioni per $4,919,635.00 e 75,350 azioni nell'ambito di un piano 10b5-1 per $1,966,921.33. La vendita proposta rappresenta circa il 0.0045% delle 1,665,262,233 azioni in circolazione riportate nella documentazione, e il dichiarante attesta l'assenza di informazioni materiali sfavorevoli non divulgate.
El insider de Coupang Gaurav Anand presentó el Form 144 para notificar la propuesta de venta de 75,350 acciones ordinarias, con un valor de mercado agregado de $2,096,990.50, que se ejecutaría en o alrededor del 08/11/2025 a través de Morgan Stanley Smith Barney LLC en la NYSE. La presentación indica que esas acciones fueron adquiridas mediante opciones sobre acciones ejercidas previamente el 10/21/2020 (12,100 acciones) y el 12/13/2021 (63,250 acciones), con pago en efectivo. El aviso también informa ventas recientes en mayo de 2025 por la misma persona: 175,000 acciones por $4,919,635.00 y 75,350 acciones bajo un plan 10b5-1 por $1,966,921.33. La venta propuesta representa aproximadamente el 0.0045% de las 1,665,262,233 acciones en circulación informadas en la presentación, y el declarante afirma no poseer información adversa material no divulgada.
쿠팡 내부자 Gaurav Anand는 예정된 75,350 보통주 매각을 통지하기 위해 Form 144를 제출했으며, 총 시장 가치는 $2,096,990.50이고 08/11/2025경 NYSE에서 Morgan Stanley Smith Barney LLC를 통해 실행될 예정입니다. 제출서류에 따르면 이 주식들은 이전에 행사된 주식옵션으로 취득되었으며, 10/21/2020에 12,100주와 12/13/2021에 63,250주를 현금으로 지급하여 취득한 것으로 나타납니다. 통지서는 또한 동일 인물의 최근 2025년 5월 매각도 보고했는데, 175,000주를 $4,919,635.00에 매도했고, 10b5-1 계획에 따른 75,350주를 $1,966,921.33에 매도했습니다. 제안된 매각은 제출서류에 보고된 유통 주식 1,665,262,233주의 약 0.0045%에 해당하며, 제출자는 공개되지 않은 중대한 불리한 정보가 없음을 확인했습니다.
L'initié de Coupang, Gaurav Anand, a déposé un Form 144 pour notifier la vente proposée de 75,350 actions ordinaires, pour une valeur de marché totale de $2,096,990.50, devant être exécutée aux alentours du 08/11/2025 via Morgan Stanley Smith Barney LLC sur le NYSE. Le dossier indique que ces actions avaient été acquises par l'exercice antérieur d'options sur actions le 10/21/2020 (12,100 actions) et le 12/13/2021 (63,250 actions), avec paiement en espèces. L'avis signale également des ventes récentes en mai 2025 par la même personne : 175,000 actions pour $4,919,635.00 et 75,350 actions dans le cadre d'un plan 10b5-1 pour $1,966,921.33. La vente proposée représente environ 0.0045% des 1,665,262,233 actions en circulation déclarées dans le dossier, et le déclarant affirme ne détenir aucune information défavorable matérielle non divulguée.
Der Coupang-Insider Gaurav Anand reichte ein Form 144 ein, um einen geplanten Verkauf von 75,350 Stammaktien anzumelden, mit einem Gesamtmarktwert von $2,096,990.50, der am oder um den 08/11/2025 über Morgan Stanley Smith Barney LLC an der NYSE ausgeführt werden soll. Aus der Einreichung geht hervor, dass diese Aktien durch zuvor ausgeübte Aktienoptionen erworben wurden am 10/21/2020 (12,100 Aktien) und am 12/13/2021 (63,250 Aktien), mit Barzahlung. Die Mitteilung meldet außerdem jüngste Verkäufe im Mai 2025 derselben Person: 175,000 Aktien für $4,919,635.00 und 75,350 Aktien im Rahmen eines 10b5-1-Plans für $1,966,921.33. Der vorgeschlagene Verkauf entspricht etwa 0.0045% der in der Einreichung genannten 1,665,262,233 im Umlauf befindlichen Aktien, und der Meldende bestätigt, dass keine nicht offengelegten wesentlichen nachteiligen Informationen vorliegen.
FAQ
What did Coupang insider Gaurav Anand disclose in the Form 144 (CPNG)?
How were the shares being sold by the filer acquired?
Has the filer sold shares recently before this Form 144?
What portion of outstanding shares does the proposed sale represent?
Which broker is handling the proposed sale?
